Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,967 public trials 1,828 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Recruiting

Hypofractionation Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse B-cell Lymphoma With Baseline High Tumor Burden

NCT06867536

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

NCT06928662

Conditions: Acute Myeloid Leukemia, Acute Undifferentiated Leukemia, Bone Marrow Diseases, +32 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

NCT07284641

Conditions: 22q11 Deletion Syndrome, Abnormalities, Multiple, Blood Protein Disorders, +56 more
Locations: UPMC Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

CD19/CD22 CAR-T as First-line Consolidation in Follicular Lymphoma

NCT07587840

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies

NCT06879340

Conditions: B-Cell Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +16 more
Locations: University of Kansas Cancer Center Westwood, Kansas, United States

View Trial Details

Recruiting

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

NCT07566377

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +21 more
Locations: Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States

View Trial Details

Recruiting

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

NCT03779854

Conditions: Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, +54 more
Locations: Children's Hospital of Los Angeles Los Angeles, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

Children's Healthcare of Atlanta Atlanta, Georgia, United States

University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States

View Trial Details

Recruiting

Obinutuzumab, Zanubrutinib, and Lenalidomide in First-line Treatment of Mantle Cell Lymphoma

NCT07261163

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing

NCT05794880

Conditions: Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Anemia, +44 more
Locations: Children's Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Recruiting

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

NCT05272384

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +15 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

Yale University New Haven, Connecticut, United States

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions